Rhinomed Limited confirmed that it has entered into a supply agreement with BTNX Inc. The supply agreement is for a period of 24 months and covers the supply of Rhinoswab and Rhinoswab Junior for inclusion in BTNX's range of Covid-19 Rapid Response antigen test kits. This includes supply of Rhinoswab Junior for inclusion in the new Rapid Response COVID-19 Antigen Rapid Test Cassette - Junior Home Test Featuring Rhinoswab Junior - one of the world's first rapid antigen test kits designed for children. BTNX and Rhinomed can advise that the supply agreement contains standard terms for an agreement of this nature and provides for a minimum binding commitment of 22.5 million swabs over a 24 month period.

The agreement is exclusive in the Canadian market and non-exclusive in all other markets. BTNX has informed Rhinomed orders will commence in July 2022.